FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease

29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...

Read more →

FDA grants Micro Interventional Devices breakthrough device designation for the MIA-T percutaneous tricuspid annuloplasty system

27 May 2021 - Micro Interventional Devices has received breakthrough device designation from the U.S. FDA for its MIA-T percutaneous ...

Read more →

Lantheus receives U.S. FDA approval of Pylarify (piflufolastat F 18) injection, the first and only commercially available PSMA PET imaging agent for prostate cancer

27 May 2021 - Pylarify will be available immediately to imaging centres in parts of the mid-Atlantic and southern regions and ...

Read more →

'Anticancer drug should extend life for 22 months to get insurance benefits'

27 May 2021 - A research team at National Cancer Center has found that the public believes that for an ...

Read more →

7 out of 10 Koreans want cheaper drug with same ingredient

27 May 2021 - Seven out of 10 Koreans want to lower the drug cost by choosing a cheaper generic ...

Read more →

Foresee Pharmaceuticals announces FDA approval of Camcevi for the treatment of advanced prostate cancer; Accord BioPharma to head the U.S. commercialisation

26 May 2021 - Foresee Pharmaceuticals announced today that the U.S. FDA has approved the new drug application for Camcevi 42 ...

Read more →

U.S. Food and Drug Administration grants BCMA CAR-T cilta-cel priority review for the treatment for relapsed/refractory multiple myeloma

26 May 2021 - Legend Biotech has announced that the U.S. FDA has accepted for priority review the biologics license application ...

Read more →

FDA authorises additional monoclonal antibody for treatment of COVID-19

26 May 2021 - Today, the U.S. FDA issued an emergency use authorisation for the investigational monoclonal antibody therapy sotrovimab for ...

Read more →

Mezzion's new drug application for its orphan drug udenafil for the treatment of single ventricle heart disease has been accepted for filing by the FDA

25 May 2021 - Mezzion Pharma is pleased to announce today that it has received notice from the FDA that ...

Read more →

More GPs to join the COVID-19 vaccine rollout

27 May 2021 - The role of general practices in the COVID-19 vaccine rollout is set to expand, with up to ...

Read more →

COVID-19 vaccine weekly safety report (27 May 2021)

27 May 2021 - Nine additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

EU seeks large AstraZeneca fine

26 May 2021 - A lawyer for the European Union has accused AstraZeneca of failing to respect its contract with ...

Read more →

Influencers say they were urged to criticise Pfizer vaccine

26 May 2021 - A disinformation effort to reduce public confidence in COVID-19 vaccines tried to enrol social media commentators in ...

Read more →

Prime Therapeutics launches MedDrive, a first of its kind medical drug management program uniquely aligned with its Blue Plan clients

26 May 2021 - MedDrive to tackle the toughest challenges facing growing medical Rx drug spend, harness the multi-billion dollar potential ...

Read more →

FDA announces draft guidances to help increase transparency, assist reporting and timely completion for certain medical device studies after FDA approval or clearance

26 May 2021 - Today, the U.S. FDA issued two guidances regarding the surveillance of certain medical devices. ...

Read more →

Medical device regulation comes into application

26 May 2021 - The medical device regulation, which was adopted in April 2017, changes the European legal framework for medical ...

Read more →